切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2013, Vol. 07 ›› Issue (04) : 269 -272. doi: 10.3877/cma.j.issn.1674-0793.2013.04.007

所属专题: 文献

论著

乌司他丁联合抗真菌药物治疗侵袭性念珠菌感染的实验研究
李小悦1, 黄顺伟2, 陈娟2, 江智毅2, 管向东2,()   
  1. 1. 东莞市人民医院ICU
    2. 中山大学附属第一医院SICU
  • 收稿日期:2012-12-22 出版日期:2013-08-01
  • 通信作者: 管向东
  • 基金资助:
    广东省医学科研基金(A2010150); 天普研究基金(01200909); 中山大学学生业余科研基金(2010045)

Effects of Ulinastatin in treatment of invasive Candida infections

Xiao-yue LI1, Shun-wei HUANG2, Juan CHEN2, Zhi-yi JIANG2, Xiang-dong GUAN2,()   

  1. 1. Department of Intensive Care Unit, Dongguan People's Hospital, Dongguan 523059, China
  • Received:2012-12-22 Published:2013-08-01
  • Corresponding author: Xiang-dong GUAN
  • About author:
    Corresponding author: GUAN Xiang-dong, Email:
引用本文:

李小悦, 黄顺伟, 陈娟, 江智毅, 管向东. 乌司他丁联合抗真菌药物治疗侵袭性念珠菌感染的实验研究[J/OL]. 中华普通外科学文献(电子版), 2013, 07(04): 269-272.

Xiao-yue LI, Shun-wei HUANG, Juan CHEN, Zhi-yi JIANG, Xiang-dong GUAN. Effects of Ulinastatin in treatment of invasive Candida infections[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2013, 07(04): 269-272.

目的

探讨乌司他丁联合抗真菌药物治疗侵袭性念珠菌感染的有效性和可能机制。

方法

雄性昆明小鼠60只,经CTX预处理后腹腔注射白念珠菌混悬液,制作侵袭性念珠菌感染小鼠模型,随机分成对照组(n=20)、低剂量组(n=20)和高剂量组(n=20)。对照组给予抗真菌药物治疗,低剂量组给予抗真菌药物联合乌司他丁(1×104 U/kg)治疗,高剂量组给予抗真菌药物联合乌司他丁(5×104 U/kg)治疗,观察3组7 d生存率、肝组织细胞因子和血淋巴细胞亚群水平。

结果

侵袭性念珠菌感染小鼠模型制作成功。高剂量组第7天生存率显著高于对照组(70% vs 30%,P =0.011)。低剂量组和高剂量组第7天肝组织IL-10均显著低于对照组(P < 0.05)。低剂量组和高剂量组第7天小鼠CD4+/CD8+比例均显著高于对照组(P < 0.05)。

结论

高剂量乌司他丁可以改善侵袭性念珠菌感染小鼠7 d生存率,机制可能与提高细胞免疫功能和降低免疫抑制的发生有关。

Objective

To investigate the effects and mechanism of Ulinastatin(UTI) combined with antifungal agents in treatment of invasive Candida infections (ICI).

Methods

Sixty Kunming mice were randomly assigned to control group, low-dose group and high-dose group (20 in each group). The model of ICI was reproduced by intraperitoneal injection of White monilial suspension after CTX pretreatment. Mice in control group were treated with antifungal agents. Mice in low-dose group and high-dose group were treated with UTI (1×104 U/kg or 5×104 U/kg) and antifungal agents. Survival rate, cytokine in liver tissue and blood lymphocyte subsets were compared among these groups.

Results

There was significant difference in survival rate between control group (30%) and high-dose group (70%), P =0.011. There was no significant difference in survival rate between other groups. There were significant differences in IL-10 among three groups, P < 0.05. There were significant differences in CD3+ rate, CD4+ rate and CD8+ rate between control group and high-dose group, P < 0.05. There were significant differences in CD4+/CD8+ rate among three groups, P < 0.05.

Conclusion

High-dose UTI can improve survival rate in mice with ICI through improving cellular immune and reducing immunosuppression.

表1 3组小鼠建模后第7天肝组织细胞因子水平(pg/ml)
表2 3组小鼠建模后第7天淋巴细胞亚群
1
Leroy O, Gangneux JP, Montravers P, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France(2005-2006). Crit Care Med, 2009, 37(5): 1612-1618.
2
Taira M, Katsura H, Kadoriku C, et al. A case of chronic necrotizing pulmonary aspergillosis successfully treated with combination therapy of antifungal drugs and ulinastatin. Nihon Kyobu Shikkan Gakkai Zasshi, 1997, 35(9): 991-995.
3
吕沛华,赵蓓蕾,施毅, 等. 侵袭性肺部真菌感染动物模型制作及血浆β-葡聚糖检测的诊断价值. 中华医院感染学杂志, 2007, 17(11): 1328-1331.
4
Guery BP, Arendrup MC, Auzinger G, et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients. Intensive Care Med, 2009, 35(1): 55-62.
5
Webster NR, Galley HF. Immunomodulation in the critically ill. Br J Anaesth, 2009, 103(1): 70-81.
6
何忠杰,刘双庆. 重症医学感染的管理[J/CD]. 中华普通外科学文献:电子版, 2011, 5(4): 277-280.
7
黄顺伟,管向东. 创伤严重脓毒症和MODS免疫调理治疗的临床研究. 中国实用外科杂志, 2006, 26(12): 932-936.
8
黄顺伟,管向东. 创伤性严重脓毒症和多器官功能障碍综合征免疫调理治疗的临床研究和远期评价. 中国危重病急救医学, 2006, 18(11): 653-656.
9
Inoue K, Takano H, Yanagisawa R, et al. Protective Effects of Urinary Trypsin Inhibitor on Systemic Inflammatory Response Induced by Lipopolysaccharide. J Clin Biochem Nutr, 2008, 43(3): 139-142.
10
Ueki M, Taie S, Chujo K, et al. Urinary Trypsin Inhibitor Reduces Inflammatory Response in Kidney Induced by Lipopolysaccharide. J Biosc Bioeng, 2007, 104(4): 315-320.
[1] 蒋敏, 刘馨竹, 李大伟, 冯柏塨, 申传安. 点阵CO2激光联合其他非手术方式治疗痤疮瘢痕有效性的网状荟萃分析[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 429-439.
[2] 陈波, 彭超, 谭小辉, 王国仲, 涂元茂. ESD治疗十二指肠非壶腹部侧向发育型肿瘤的安全性和有效性研究[J/OL]. 中华普外科手术学杂志(电子版), 2022, 16(02): 222-225.
[3] 黄建朋, 邹建强, 宗华. 肝移植术后腹壁疝诊治初步经验[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(04): 471-473.
[4] 王红敏, 谢云波, 王彦虎, 王福生. 间充质干细胞治疗新冠病毒感染的临床研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 247-256.
[5] 范清泉, 宋晓玲, 翁明哲, 顾钧. 消化道重建术后ERCP安全性和疗效分析[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 331-335.
[6] 顾一帆, 潘璐. 关注近视眼防控措施及其面临的形势[J/OL]. 中华眼科医学杂志(电子版), 2024, 14(03): 129-133.
[7] 娜荷雅, 朱丹. 红光疗法在儿童近视眼防控中的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(04): 252-256.
[8] 赵艳, 朱丹. 低浓度阿托品在儿童近视眼防控中应用的研究进展[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(02): 124-128.
[9] 徐清华, 张振林, 李浩. 清胰汤联合乌司他丁对急性胰腺炎患者肠道功能恢复及炎性因子水平的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(03): 253-257.
[10] 周嫏嬛, 龚伟玲, 孙孚春, 宋颂. 生长抑素联合乌司他丁治疗消化道出血的Meta分析[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(01): 26-32.
[11] 曹文玺, 陈箫, 竺来法, 周永平. 尼妥珠单抗联合白蛋白结合型紫杉醇治疗胰腺癌的有效性及安全性分析[J/OL]. 中华临床医师杂志(电子版), 2023, 17(04): 409-413.
[12] 王敏, 刘虹. 乌司他丁经p38MAPK通路对脓毒症大鼠急性肾损伤影响的研究[J/OL]. 中华临床医师杂志(电子版), 2022, 16(06): 566-571.
[13] 王勇, 王丽. 导管接触性溶栓治疗下肢深静脉血栓安全性和有效性的系统评价再评价[J/OL]. 中华介入放射学电子杂志, 2024, 12(01): 58-63.
[14] 黄建朋, 杨骏波, 朱胜彬, 宗华. 3例HIV感染的肥胖患者袖状胃手术的安全性与有效性观察[J/OL]. 中华肥胖与代谢病电子杂志, 2023, 09(01): 68-71.
[15] 李承玉, 徐连萍, 王圣松, 王群. 不同抗癫痫发作药物单药治疗在卒中后癫痫中的保留率和有效性分析[J/OL]. 中华脑血管病杂志(电子版), 2023, 17(04): 325-330.
阅读次数
全文


摘要